Collegium Ends Grünenthal Nucynta U.S. License in $17 Million Settlement
Collegium Pharmaceutical and Grünenthal settled disputes related to Nucynta, including pending patent litigation over the authorized generic for Nucynta ER. They mutually terminated their 2015 U.S. License Agreement.